Herpes simplex virus type 2 triggers reactivation of Kaposi's sarcoma-associated herpesvirus from latency and collaborates with HIV-1 tat

PLoS ONE

Volumn 7, Issue 2, 2012, Pages

  Tang, Qiao ^a,b   Qin, Di ^a   Lv, Zhigang ^a,c   Zhu, Xiaolei ^a   Ma, Xinting ^a   Yan, Qin ^a   Zeng, Yi ^d   Guo, Yuanyuan ^a   Feng, Ninghan ^b   Lu, Chun ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^c Jiangsu Province Official Hospital   (China)

^d YOUJIANG MEDICAL COLLEGE FOR NATIONALITIES   (China)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TRANSACTIVATOR PROTEIN;

ANIMAL CELL; ARTICLE; CELL DIVISION; CELL STRUCTURE; CONTROLLED STUDY; ENZYME ACTIVITY; GENETIC TRANSCRIPTION; HERPES SIMPLEX VIRUS 2; HUMAN; HUMAN CELL; HUMAN HERPESVIRUS 8; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; PROMOTER REGION; PROTEIN BINDING; RNA INTERFERENCE; SIGNAL TRANSDUCTION; VIRION; VIRUS ACTIVATION; VIRUS PARTICLE; VIRUS REACTIVATION; VIRUS REPLICATION; KAPOSI SARCOMA; METABOLISM; PHYSIOLOGY; VIROLOGY; VIRUS LATENCY;

HERPESVIRUS 2, HUMAN; HERPESVIRUS 8, HUMAN; HUMANS; NF-KAPPA B; SARCOMA, KAPOSI; TAT GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; VIRUS ACTIVATION; VIRUS LATENCY;

EID: 84863039895     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0031652     Document Type: Article

References (54)

1. Chang Y, Cesarman E, Pessin MS, Lee F, Culpepper J, et al. (1994) Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 266: 1865-1869.
2. Arora A, Chiao E, Tyring SK, (2007) AIDS malignancies. Cancer Treat Res 133: 21-67.
3. Sunil M, Reid E, Lechowicz MJ, (2010) Update on HHV-8-Associated Malignancies. Curr Infect Dis Rep 12: 147-154.
4. Powles T, Stebbing J, Bazeos A, Hatzimichael E, Mandalia S, et al. (2009) The role of immune suppression and HHV-8 in the increasing incidence of HIV-associated multicentric Castleman's disease. Ann Oncol 20: 775-779.
5. Katano H, Sata T, (2000) Human herpesvirus 8 virology, epidemiology and related diseases. Jpn J Infect Dis 53: 137-155.
6. Ganem D, (2010) KSHV and the pathogenesis of Kaposi sarcoma: listening to human biology and medicine. J Clin Invest 120: 939-949.
7. Deng H, Liang Y, Sun R, (2007) Regulation of KSHV lytic gene expression. Curr Top Microbiol Immunol 312: 157-183.
8. Staudt MR, Dittmer DP, (2007) The Rta/Orf50 transactivator proteins of the gamma-herpesviridae. Curr Top Microbiol Immunol 312: 71-100.
9. Vieira J, O'Hearn P, Kimball L, Chandran B, Corey L, (2001) Activation of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) lytic replication by human cytomegalovirus. J Virol 75: 1378-1386.
10. Lu C, Zeng Y, Huang Z, Huang L, Qian C, et al. (2005) Human herpesvirus 6 activates lytic cycle replication of Kaposi's sarcoma-associated herpesvirus. Am J Pathol 166: 173-183.
11. Qin D, Zeng Y, Qian C, Huang Z, Lv Z, et al. (2008) Induction of lytic cycle replication of Kaposi's sarcoma-associated herpesvirus by herpes simplex virus type 1: involvement of IL-10 and IL-4. Cell Microbiol 10: 713-728.
12. Zeng Y, Zhang X, Huang Z, Cheng L, Yao S, et al. (2007) Intracellular Tat of human immunodeficiency virus type 1 activates lytic cycle replication of Kaposi's sarcoma-associated herpesvirus: role of JAK/STAT signaling. J Virol 81: 2401-2417.
13. Varthakavi V, Browning PJ, Spearman P, (1999) Human immunodeficiency virus replication in a primary effusion lymphoma cell line stimulates lytic-phase replication of Kaposi's sarcoma-associated herpesvirus. J Virol 73: 10329-10338.
14. Gray R, Wilson D, (2010) Acyclovir and transmission of HIV-1 from persons infected with HIV-1 and HSV-2. N Engl J Med 362: 1740; author reply 1741-1742.
15. Canadas MP, Videla S, Darwich L, Tarrats A, Pinol M, et al. (2010) Human papillomavirus HPV-16, 18, 52 and 58 integration in cervical cells of HIV-1-infected women. J Clin Virol.
16. Tan DH, Kaul R, Walsmley S, (2009) Left out but not forgotten: Should closer attention be paid to coinfection with herpes simplex virus type 1 and HIV? Can J Infect Dis Med Microbiol 20: e1-7.
17. Nikolic DS, Piguet V, (2010) Vaccines and microbicides preventing HIV-1, HSV-2, and HPV mucosal transmission. J Invest Dermatol 130: 352-361.
18. Sarmati L, Babudieri S, Longo B, Starnini G, Carbonara S, et al. (2007) Human herpesvirus 8 and human herpesvirus 2 infections in prison population. J Med Virol 79: 167-173.
19. Suligoi B, Danaya RT, Sarmati L, Owen IL, Boros S, et al. (2005) Infection with human immunodeficiency virus, herpes simplex virus type 2, and human herpes virus 8 in remote villages of southwestern Papua New Guinea. Am J Trop Med Hyg 72: 33-36.
20. Volpi A, Sarmati L, Suligoi B, Montano M, Rezza G, et al. (2004) Correlates of human herpes virus-8 and herpes simplex virus type 2 infections in Northern Cameroon. J Med Virol 74: 467-472.
21. Kao YS, Sundin DR, Gebhardt BM, (1999) Persistent infection of a lymphoma cell line by herpes simplex virus. Am J Hematol 62: 93-98.
22. Kim YC, Bang D, Lee S, Lee KH, (2000) The effect of herpesvirus infection on the expression of cell adhesion molecules on cultured human dermal microvascular endothelial cells. J Dermatol Sci 24: 38-47.
23. Johnston C, Magaret A, Selke S, Remington M, Corey L, et al. (2008) Herpes simplex virus viremia during primary genital infection. J Infect Dis 198: 31-34.
24. Ensoli B, Buonaguro L, Barillari G, Fiorelli V, Gendelman R, et al. (1993) Release, uptake, and effects of extracellular human immunodeficiency virus type 1 Tat protein on cell growth and viral transactivation. J Virol 67: 277-287.
25. Hancock MH, Cliffe AR, Knipe DM, Smiley JR, (2010) Herpes simplex virus VP16, but not ICP0, is required to reduce histone occupancy and enhance histone acetylation on viral genomes in U2OS osteosarcoma cells. J Virol 84: 1366-1375.
26. Palliser D, Chowdhury D, Wang QY, Lee SJ, Bronson RT, et al. (2006) An siRNA-based microbicide protects mice from lethal herpes simplex virus 2 infection. Nature 439: 89-94.
27. Muller WJ, Dong L, Vilalta A, Byrd B, Wilhelm KM, et al. (2009) Herpes simplex virus type 2 tegument proteins contain subdominant T-cell epitopes detectable in BALB/c mice after DNA immunization and infection. J Gen Virol 90: 1153-1163.
28. Bergstrom T, Trybala E, (1996) Antigenic differences between HSV-1 and HSV-2 glycoproteins and their importance for type-specific serology. Intervirology 39: 176-184.
29. Sun R, Lin SF, Staskus K, Gradoville L, Grogan E, et al. (1999) Kinetics of Kaposi's sarcoma-associated herpesvirus gene expression. J Virol 73: 2232-2242.
30. O'Neill E, Douglas JL, Chien ML, Garcia JV, (1997) Open reading frame 26 of human herpesvirus 8 encodes a tetradecanoyl phorbol acetate- and butyrate-inducible 32-kilodalton protein expressed in a body cavity-based lymphoma cell line. J Virol 71: 4791-4797.
31. Blauvelt A, Herndier BG, Orenstein JM, (1997) Propagation of a human herpesvirus from AIDS-associated Kaposi's sarcoma. N Engl J Med 336: 1837-1839.
32. Sgarbanti M, Arguello M, tenOever BR, Battistini A, Lin R, et al. (2004) A requirement for NF-kappaB induction in the production of replication-competent HHV-8 virions. Oncogene 23: 5770-5780.
33. Brown HJ, Song MJ, Deng H, Wu TT, Cheng G, et al. (2003) NF-kappaB inhibits gammaherpesvirus lytic replication. J Virol 77: 8532-8540.
34. Ye FC, Zhou FC, Xie JP, Kang T, Greene W, et al. (2008) Kaposi's sarcoma-associated herpesvirus latent gene vFLIP inhibits viral lytic replication through NF-kappaB-mediated suppression of the AP-1 pathway: a novel mechanism of virus control of latency. J Virol 82: 4235-4249.
35. Sun Q, Matta H, Lu G, Chaudhary PM, (2006) Induction of IL-8 expression by human herpesvirus 8 encoded vFLIP K13 via NF-kappaB activation. Oncogene 25: 2717-2726.
36. Izumiya Y, Izumiya C, Hsia D, Ellison TJ, Luciw PA, et al. (2009) NF-kappaB serves as a cellular sensor of Kaposi's sarcoma-associated herpesvirus latency and negatively regulates K-Rta by antagonizing the RBP-Jkappa coactivator. J Virol 83: 4435-4446.
37. Grossmann C, Ganem D, (2008) Effects of NFkappaB activation on KSHV latency and lytic reactivation are complex and context-dependent. Virology 375: 94-102.
38. Malope BI, MacPhail P, Mbisa G, MacPhail C, Stein L, et al. (2008) No evidence of sexual transmission of Kaposi's sarcoma herpes virus in a heterosexual South African population. AIDS 22: 519-526.
39. Varthakavi V, Smith RM, Deng H, Sun R, Spearman P, (2002) Human immunodeficiency virus type-1 activates lytic cycle replication of Kaposi's sarcoma-associated herpesvirus through induction of KSHV Rta. Virology 297: 270-280.
40. Merat R, Amara A, Lebbe C, de The H, Morel P, et al. (2002) HIV-1 infection of primary effusion lymphoma cell line triggers Kaposi's sarcoma-associated herpesvirus (KSHV) reactivation. Int J Cancer 97: 791-795.
41. Lei X, Bai Z, Ye F, Xie J, Kim CG, et al. (2010) Regulation of NF-kappaB inhibitor IkappaBalpha and viral replication by a KSHV microRNA. Nat Cell Biol 12: 193-199.
42. Li X, Feng J, Sun R, (2011) Oxidative stress induces reactivation of Kaposi's sarcoma-associated herpesvirus and death of primary effusion lymphoma cells. J Virol 85: 715-724.
43. Zhu X, Zhou F, Qin D, Zeng Y, Lv Z, et al. (2011) Human immunodeficiency virus type 1 induces lytic cycle replication of Kaposi's-sarcoma-associated herpesvirus: role of Ras/c-Raf/MEK1/2, PI3K/AKT, and NF-kappaB signaling pathways. J Mol Biol 410: 1035-1051.
44. Li H, Li X, Wei Y, Tan Y, Liu X, et al. (2009) HSV-2 induces TLRs and NF-kappaB-dependent cytokines in cervical epithelial cells. Biochem Biophys Res Commun 379: 686-690.
45. Malmgaard L, Paludan SR, Mogensen SC, Ellermann-Eriksen S, (2000) Herpes simplex virus type 2 induces secretion of IL-12 by macrophages through a mechanism involving NF-kappaB. J Gen Virol 81: 3011-3020.
46. Chen X, Cheng L, Jia X, Zeng Y, Yao S, et al. (2009) Human immunodeficiency virus type 1 Tat accelerates Kaposi sarcoma-associated herpesvirus Kaposin A-mediated tumorigenesis of transformed fibroblasts in vitro as well as in nude and immunocompetent mice. Neoplasia 11: 1272-1284.
47. Ostrove JM, Leonard J, Weck KE, Rabson AB, Gendelman HE, (1987) Activation of the human immunodeficiency virus by herpes simplex virus type 1. J Virol 61: 3726-3732.
48. Schafer SL, Vlach J, Pitha PM, (1996) Cooperation between herpes simplex virus type 1-encoded ICP0 and Tat to support transcription of human immunodeficiency virus type 1 long terminal repeat in vivo can occur in the absence of the TAR binding site. J Virol 70: 6937-6946.
49. Palu G, Benetti L, Calistri A, (2001) Molecular basis of the interactions between herpes simplex viruses and HIV-1. Herpes 8: 50-55.
50. Akhtar J, Shukla D, (2009) Viral entry mechanisms: cellular and viral mediators of herpes simplex virus entry. FEBS J 276: 7228-7236.
51. Koelle DM, Corey L, (2008) Herpes simplex: insights on pathogenesis and possible vaccines. Annu Rev Med 59: 381-395.
52. Qin D, Feng N, Fan W, Ma X, Yan Q, et al. (2011) Activation of PI3K/AKT and ERK MAPK signal pathways is required for the induction of lytic cycle replication of Kaposi's sarcoma-associated herpesvirus by herpes simplex virus type 1. BMC Microbiol 11: 240.
53. Krishnan HH, Naranatt PP, Smith MS, Zeng L, Bloomer C, et al. (2004) Concurrent expression of latent and a limited number of lytic genes with immune modulation and antiapoptotic function by Kaposi's sarcoma-associated herpesvirus early during infection of primary endothelial and fibroblast cells and subsequent decline of lytic gene expression. J Virol 78: 3601-3620.
54. Kim S, Domon-Dell C, Kang J, Chung DH, Freund JN, et al. (2004) Down-regulation of the tumor suppressor PTEN by the tumor necrosis factor-alpha/nuclear factor-kappaB (NF-kappaB)-inducing kinase/NF-kappaB pathway is linked to a default IkappaB-alpha autoregulatory loop. J Biol Chem 279: 4285-4291.